Log in to your Inderes Free account to see all free content on this page.
Attana
0.01 SEK
Less than 1K followers
ATANA
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Attana
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 6.5 | 4.2 | 1.6 | 7.6 | 5.1 | 4.1 | 2.5 |
| growth-% | -35.3 % | -61.7 % | 375.0 % | -33.6 % | -18.8 % | -39.7 % | |
| EBITDA | -5.3 | -7.7 | -13.9 | -11.5 | -10.2 | -4.5 | -8.9 |
| EBIT | -7.0 | -9.9 | -16.5 | -14.2 | -12.4 | -10.0 | -10.6 |
| Profit before taxes | -7.4 | -10.6 | -16.7 | -14.6 | -13.8 | -12.8 | -11.0 |
| Net income | -7.4 | -10.6 | -16.7 | -14.6 | -13.8 | -12.8 | -11.0 |
| EPS | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 | -0.02 | -0.01 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -81.4 % | -183.5 % | -866.9 % | -150.7 % | -202.0 % | -110.5 % | -358.7 % |
| EBIT-% | -107.5 % | -237.1 % | -1,030.0 % | -186.4 % | -245.7 % | -244.1 % | -429.9 % |
| ROE | -50.5 % | -22.3 % | -53.8 % | -90.0 % | -75.0 % | -70.5 % | -57.9 % |
| ROI | -36.9 % | -17.8 % | -45.3 % | -50.2 % | -42.0 % | -52.0 % | -45.5 % |
Login required
This content is only available for logged in users